Your browser doesn't support javascript.
loading
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Jo, Tomoyasu; Arai, Yasuyuki; Kondo, Tadakazu; Mizuno, Shohei; Hirabayashi, Shigeki; Inamoto, Yoshihiro; Doki, Noriko; Fukuda, Takahiro; Ozawa, Yukiyasu; Katayama, Yuta; Kanda, Yoshinobu; Fukushima, Kentaro; Matsuoka, Ken-Ichi; Takada, Satoru; Sawa, Masashi; Ashida, Takashi; Onizuka, Makoto; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Junya; Yanada, Masamitsu.
  • Jo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Research and Application of Cellular Therapy, Kyoto University Hospital, Kyoto, Japan.
  • Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Research and Application of Cellular Therapy, Kyoto University Hospital, Kyoto, Japan. Electronic address: ysykrai@kuhp.kyoto-u.ac.jp.
  • Kondo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Hirabayashi S; Division of Precision Medicine, Kyusyu University School of Medicine, Fukuoka, Japan.
  • Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Doki N; Hematology Division, Komagome Hospital, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Fukushima K; Department of Hematology and Oncology, Osaka University Hospital, Osaka, Japan.
  • Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Ashida T; Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital, Osakasayama, Japan.
  • Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Cytotherapy ; 24(10): 1013-1025, 2022 10.
Article en En | MEDLINE | ID: mdl-35729020

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre de Sangre Periférica / Células Madre de Sangre Periférica / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre de Sangre Periférica / Células Madre de Sangre Periférica / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article